342 related articles for article (PubMed ID: 31229365)
1. Management of the neck after definitive chemoradiation in patients with HPV-associated oropharyngeal cancer: An institutional experience.
Wotman M; Ghaly M; Massaro L; Tham T; Seetharamu N; Kamdar D; Frank D; Kraus D; Teckie S
Am J Otolaryngol; 2019; 40(5):684-690. PubMed ID: 31229365
[TBL] [Abstract][Full Text] [Related]
2. Retrospective review of positron emission tomography with contrast-enhanced computed tomography in the posttreatment setting in human papillomavirus-associated oropharyngeal carcinoma.
Chan JY; Sanguineti G; Richmon JD; Marur S; Gourin CG; Koch W; Chung CH; Quon H; Bishop JA; Aygun N; Agrawal N
Arch Otolaryngol Head Neck Surg; 2012 Nov; 138(11):1040-6. PubMed ID: 23165378
[TBL] [Abstract][Full Text] [Related]
3. (18)F-FDG PET/CT to assess response and guide risk-stratified follow-up after chemoradiotherapy for oropharyngeal squamous cell carcinoma.
Bird T; Barrington S; Thavaraj S; Jeannon JP; Lyons A; Oakley R; Simo R; Lei M; Guerrero Urbano T
Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1239-47. PubMed ID: 26707387
[TBL] [Abstract][Full Text] [Related]
4. Earlier and more specific detection of persistent neck disease with diffusion-weighted MRI versus subsequent PET/CT after definitive chemoradiation for oropharyngeal squamous cell carcinoma.
Yu Y; Mabray M; Silveira W; Shen PY; Ryan WR; Uzelac A; Yom SS
Head Neck; 2017 Mar; 39(3):432-438. PubMed ID: 27726241
[TBL] [Abstract][Full Text] [Related]
5. ACR Appropriateness Criteria(®) Locoregional therapy for resectable oropharyngeal squamous cell carcinomas.
Beitler JJ; Quon H; Jones CU; Salama JK; Busse PM; Cooper JS; Koyfman SA; Ridge JA; Saba NF; Siddiqui F; Smith RV; Worden F; Yao M; Yom SS;
Head Neck; 2016 Sep; 38(9):1299-309. PubMed ID: 27330003
[TBL] [Abstract][Full Text] [Related]
6. Residual nodal disease in patients with advanced-stage oropharyngeal squamous cell carcinoma treated with definitive radiation therapy and posttreatment neck dissection: Association with locoregional recurrence, distant metastasis, and decreased survival.
Sandulache VC; Ow TJ; Daram SP; Hamilton J; Skinner H; Bell D; Rosenthal DI; Beadle BM; Ang KK; Kies MS; Johnson FM; El-Naggar AK; Myers JN
Head Neck; 2013 Oct; 35(10):1454-60. PubMed ID: 23018868
[TBL] [Abstract][Full Text] [Related]
7. 12 week PET-CT has low positive predictive value for nodal residual disease in human papillomavirus-positive oropharyngeal cancers.
Rulach R; Zhou S; Hendry F; Stobo D; James A; Dempsey MF; Grose D; Lamb C; Schipani S; Rizwanullah M; Wilson C; Paterson C
Oral Oncol; 2019 Oct; 97():76-81. PubMed ID: 31437587
[TBL] [Abstract][Full Text] [Related]
8. Utility of a repeat PET/CT scan in HPV-associated Oropharyngeal Cancer following incomplete nodal response from (chemo)radiotherapy.
Liu HY; Milne R; Lock G; Panizza BJ; Bernard A; Foote M; McGrath M; Brown E; Gandhi M; Porceddu SV
Oral Oncol; 2019 Jan; 88():153-159. PubMed ID: 30616786
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity in the clinical presentation, diagnosis, and treatment initiation of p16-positive oropharyngeal cancer.
Raman A; Sen N; Ritz E; Fidler MJ; Revenaugh P; Stenson K; Al-Khudari S
Am J Otolaryngol; 2019; 40(5):626-630. PubMed ID: 31174931
[TBL] [Abstract][Full Text] [Related]
10. PET/CT Poorly Predicts AJCC 8th Edition Pathologic Staging in HPV-Related Oropharyngeal Cancer.
Snyder V; Goyal LK; Bowers EMR; Kubik M; Kim S; Ferris RL; Johnson JT; Duvvuri U; Gooding WE; Branstetter BF; Rath TJ; Sridharan SS
Laryngoscope; 2021 Jul; 131(7):1535-1541. PubMed ID: 33428218
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus DNA detection in fine-needle aspirates as indicator of human papillomavirus-positive oropharyngeal squamous cell carcinoma: A prospective study.
Sivars L; Landin D; Haeggblom L; Tertipis N; Grün N; Bersani C; Marklund L; Ghaderi M; Näsman A; Ramqvist T; Nordfors C; Munck-Wikland E; Tani E; Dalianis T
Head Neck; 2017 Mar; 39(3):419-426. PubMed ID: 27898186
[TBL] [Abstract][Full Text] [Related]
12. Management of the "violated neck" in the era of chemoradiation.
Loyo M; Johnson JT; Westra WH; Chiosea SI; Gourin CG
Laryngoscope; 2011 Nov; 121(11):2349-58. PubMed ID: 21993776
[TBL] [Abstract][Full Text] [Related]
13. Planned neck dissection after chemoradiotherapy in advanced oropharyngeal squamous cell cancer: the role of US, MRI and FDG-PET/TC scans to assess residual neck disease.
Pellini R; Manciocco V; Turri-Zanoni M; Vidiri A; Sanguineti G; Marucci L; Sciuto R; Covello R; Sperduti I; Kayal R; Anelli V; Pichi B; Mercante G; Spriano G
J Craniomaxillofac Surg; 2014 Dec; 42(8):1834-9. PubMed ID: 25150165
[TBL] [Abstract][Full Text] [Related]
14. Long-term regional control in the observed neck following definitive chemoradiation for node-positive oropharyngeal squamous cell cancer.
Goenka A; Morris LG; Rao SS; Wolden SL; Wong RJ; Kraus DH; Ohri N; Setton J; Lok BH; Riaz N; Mychalczak BR; Schoder H; Ganly I; Shah JP; Pfister DG; Zelefsky MJ; Lee NY
Int J Cancer; 2013 Sep; 133(5):1214-21. PubMed ID: 23436584
[TBL] [Abstract][Full Text] [Related]
15. Oncologic outcomes of selective neck dissection in HPV-related oropharyngeal squamous cell carcinoma.
Zenga J; Jackson RS; Graboyes EM; Sinha P; Lindberg M; Martin EJ; Ma D; Thorstad WL; Rich JT; Moore EJ; Haughey BH
Laryngoscope; 2017 Mar; 127(3):623-630. PubMed ID: 27634021
[TBL] [Abstract][Full Text] [Related]
16. CT and FDG-PET radiologic biomarkers in p16+ oropharyngeal squamous cell carcinoma patients treated with definitive chemoradiotherapy.
Rosen BS; Wilkie JR; Sun Y; Ibrahim M; Casper KA; Miller JE; Chotchutipan T; Stucken CL; Bradford C; Prince MEP; Rosko AJ; Malloy KM; McLean SA; Chinn SB; Shuman AG; Spector ME; Swiecicki PL; Worden FP; Shah JL; Schonewolf CA; Chapman CH; Eisbruch A; Mierzwa ML
Radiother Oncol; 2021 Feb; 155():174-181. PubMed ID: 33069764
[TBL] [Abstract][Full Text] [Related]
17. Impact of chemotherapy regimen on treatment outcomes in patients with HPV-associated oropharyngeal cancer with T4 disease treated with definitive concurrent chemoradiation.
Bhattasali O; Ryoo JJ; Thompson LDR; Abdalla IA; Chen J; Iganej S
Oral Oncol; 2019 Aug; 95():74-78. PubMed ID: 31345397
[TBL] [Abstract][Full Text] [Related]
18. Developing a new diagnostic algorithm for human papilloma virus associated oropharyngeal carcinoma: an investigation of HPV DNA assays.
Cohen N; Gupta M; Doerwald-Munoz L; Jang D; Young JE; Archibald S; Jackson B; Lee J; Chernesky M
J Otolaryngol Head Neck Surg; 2017 Feb; 46(1):11. PubMed ID: 28193254
[TBL] [Abstract][Full Text] [Related]
19. Radiographic Imaging Does Not Reliably Predict Macroscopic Extranodal Extension in Human Papilloma Virus-Associated Oropharyngeal Cancer.
Patel MR; Hudgins PA; Beitler JJ; Magliocca KR; Griffith CC; Liu Y; Bougnon K; El-Deiry M; Saba NF; Aiken AH
ORL J Otorhinolaryngol Relat Spec; 2018; 80(2):85-95. PubMed ID: 29969771
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
